NOELLE ESKANDARI: Open Payments
NPI 1154750941 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 49 payments from 15 companies in 2025. Trend: 2023 $923 · 2024 $1,627 · 2025 $1,168
Food & beverage: $959Education: $210
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $354 |
| Janssen Biotech, Inc. | 7 | $186 |
| Incyte Corporation | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Lilly USA, LLC | 3 | $81 |
| LEO Pharma Inc. | 2 | $65 |
| GENZYME CORPORATION | 2 | $63 |
| UCB, Inc. | 2 | $50 |
| Amgen Inc. | 2 | $33 |
| Surgenex LLC | 1 | $27 |
Products named: SKYRIZI, TREMFYA, RINVOQ, DUPIXENT, Opzelura, TALTZ, ADBRY, Bimzelx.
Industry payments across AZ — which companies pay providers there.
